Background: Studies of geographic variation in hospitalizations commonly examine age-and gender-adjusted population-based hospitalization rates (ie, the numbers of persons hospitalized relative to what is expected given the age/gender distributions in the area population). Objective: To determine whether areas identified as extreme using population-based hospitalization rates remain extreme when ranked by disease-based hospitalization rates (the numbers of persons hospitalized relative to what is expected given the amount of disease in the area). Design: The authors examined 1997 Medicare data on both inpatient admissions and outpatient visits of patients 65 years and older in each of 71 small areas in Massachusetts for 15 medical conditions. For each area, the number of people having each condition was calculated as the sum of those hospitalized plus those treated as outpatients only. The authors used hierarchical Bayesian modeling to estimate area-specific population-based hospitalization rates, disease-based hospitalization rates (DHRs), and disease prevalence. Main Outcome Measure: The extent to which the same areas were identified as extreme based on population-based hospitalization rates versus DHRs. Results: Area-specific population-based hospitalization rates, DHRs, and disease prevalence varied substantially. Areas identified as extreme using population-based hospitalization rates often were not extreme when ranked by DHRs. For 11 of the 15 conditions, 5 or more of the 14 areas ranked in top and bottom deciles by population-based hospitalization rates were more likely than not (ie, with probability Ն 0.50) to be at least 2 deciles less extreme when ranked by DHRs.
M
any studies have reported large differences in age-and gender-adjusted rates of hospitalization across small geographic areas. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Studies of surgery and procedures 14 -19 and medical conditions 20 have found that higher rates of inappropriateness do not explain higher hospitalization rates. Despite this, some suggest that savings are possible without sacrificing quality of care by reducing rates in high-rate areas to levels in lower rate areas. 21, 22 This suggestion assumes that much of the variation is due to "practice style" differences, either "uncertainty" about best treatment practices 23 or "enthusiasm" for one type of treatment over another, 24 which only minimally affect health care outcomes.
Area-specific hospitalization rates are population based because denominators used in calculating the rates reflect the populations in the areas rather than the numbers of people within areas who have the disease. Differences in age-and gender-adjusted population-based hospitalization rates might be due to differences in the likelihood that patients with the disease are admitted to the hospital. Alternatively, they may reflect differences in disease prevalence.
The most widely used approach to account for differences in disease burden across areas is to adjust area-specific rates further for differences in hospitalization rates for selected marker conditions chosen as proxies for the underlying burden of illness in the population (eg, hospitalizations for hip fracture, colon or lung cancer treated surgically, acute myocardial infarction, and stroke). 25 This approach hypothesizes that hospitalization rates for the marker conditions are highly correlated with the total amount of other diseases in an area. The hypothesis has some merit, as suggested by the finding that variation in such marker conditions explains about 25% of the variation in age-, gender-, and race-adjusted Medicare spending across regions. 22 However, use of marker conditions as a proxy for the prevalence of other diseases has not been validated. Also, when examining variations in hospitalization rates for specific conditions, the conceptual justification for using markers as a measure of prevalence is weaker.
Over the last decade, several groups have developed risk assessment models that use both inpatient and ambulatory claims to identify diseases and predict costs. 26 Their success indicates that although diagnosis codes on claims forms are imperfect indicators of true disease prevalence, they contain useful information about the medical problems that are present. Especially in a Medicare population, in which most beneficiaries are insured for both inpatient and outpatient care, differences across areas in amount of disease as determined from claims forms should reflect, reasonably well, differences in underlying disease prevalence.
In this study we used Medicare data from both inpatient and outpatient claims to identify people with any of 15 medical conditions. For each condition and geographic area, we calculated both the population-based hospitalization rate (the number of people hospitalized relative to the number expected given the age/gender distribution of the population in the area) and the disease-based hospitalization rate (the number of people hospitalized relative to the number expected given the amount of disease in the area). We then examined the extent to which the same areas were ranked as either particularly high or low using the 2 measures.
METHODS

Database
We studied hospitalizations and outpatient treatment of Medicare patients older than 65 years of age in Massachusetts in 1997. Hospitalization data were obtained from the Center for Medicare and Medicaid Services (CMS, formerly the Health Care Financing Administration) MedPAR file. Outpatient data were obtained from the CMS 1997 Carrier File (claims data for part B physician/supplier services) and Outpatient File (claims data for outpatient facility charges at hospitals and other institutions). Table 1 shows the 15 medical conditions in our study, defined initially by diagnosis-related group (DRG). As described elsewhere, 27 within most DRGs we increased clinical homogeneity by considering only discharges with a principal diagnosis from selected ICD-9-CM codes. All 15 conditions had at least 1000 people hospitalized and 6000 treated as outpatients only in 1997.
Conditions
Determining Numerators and Denominators
Disease prevalence cannot be inferred from claims for Medicare beneficiaries in health maintenance organizations (HMOs; because their outpatient claims are not submitted to CMS) or those not eligible for outpatient and physician office (part B) reimbursement. Thus, we wanted to include in our analyses only non-HMO part B-eligible enrollees. We did not have individual-level eligibility information. As a proxy for part B eligibility of hospitalized patients, we only counted hospitalized patients with at least 1 part B bill in 1997 (slightly over 90% of hospitalized Medicare patients). We also eliminated from hospitalization counts the approximately 5% of discharges in the MedPAR file in which an HMO was the payer. We identified outpatient visits, including office, nursing and rest home, and home visits from CPT codes. 27 Diagnosis coding for outpatient visits is generally less reliable than inpatient coding and is governed by somewhat different rules. To reflect the potential effect of different coding rules, we used 2 methods to assign outpatient visits to conditions: one based on a "series" of outpatient visits and a second based on a single visit. For inpatients, coding guidelines instruct abstractors to code a diagnosis accompanied by such phrases as "rule out," "suspect," or "question" as if the disease had actually occurred. For outpatients, coding guidelines stipulate that only confirmed diagnoses be coded to their highest level of specificity. As a result, a series of outpatient visits may carry multiple codes as the physician attempts to confirm a diagnosis. Because we wished to capture only "final" diagnoses, we proceeded as follows: We considered any outpatient visit within 6 weeks of a previous outpatient visit to be part of the same series of visits. Only diagnostic codes on the last visit in a series were used to identify the conditions being addressed. We required a gap of at least 8 weeks (ie, an additional 2-week buffer) to establish the beginning of a new series.
We examined the sensitivity of conclusions to an approach that ignored visit series and identified the conditions being addressed based on the presence of any relevant diagnosis at any single visit. Because findings concerning the concordance between population-based and disease-based rates were similar for both approaches, we only report analyses using the "visit series" method.
We considered the numbers of people with each condition, either treated in the hospital or as outpatient only, rather than the numbers of admissions or outpatient visits, primarily because the number of people who have a diagnosis is a more direct measure of underlying disease prevalence than service counts, which also reflect practice style. 28 Most variation in overall hospitalization rates is caused by variations in the number of people hospitalized. 27 By focusing on numbers of people rather than numbers of events, we can estimate the observed amount of disease in an area as the total of people hospitalized plus those treated as outpatients only.
For each 5-year age category from 65 years and older, and for each gender, we determined the number of Medicare enrollees in each zip code in Massachusetts from the Annual Zip Code Enrollment File.
Creating Small Geographic Areas
As described elsewhere, 27, 29 we used Ward's clustering algorithm to create small geographic areas. Ward's clustering algorithm 30, 31 creates areas by combining zip codes based on similarity in the proportion of total hospital discharges from the zip code that were from each hospital. Discharges of patients with the following characteristics were used in clustering: age 65 years or older, Massachusetts resident, and discharged in 1997 from a hospital in Massachusetts paid under Medicare's Prospective Payment System. The results of the clustering were 71 small areas with the following distribution of residents 65 years and older: 20 areas had less than 5000; 21 had 5000 to 9999; 19 had 10,000 to 19,999; and 11 areas had more than 20,000.
Analysis
We considered 3 types of area-specific "relative rates" (referred to more simply as "rates"), defined as observed counts divided by expected.
• Population-based hospitalization rate ϭ number of people hospitalized relative to the number expected.
• Disease prevalence ϭ sum of people hospitalized plus those treated as outpatients only (ie, the number with the disease) relative to the number expected (we use the term prevalence rather than rate to emphasize what this rate is measuring).
• Disease-based hospitalization rate ϭ proportion of people with the disease that were hospitalized relative to the ratio of the expected number hospitalized to the expected number with the disease.
Let O ij ϭ number of people hospitalized (ie, treated as inpatients) in area j O oj ϭ number of people treated as outpatients only in area j E ij ϭ expected number of people hospitalized in area j E oj ϭ expected number of people treated as outpatients only in area j Both E ij and E oj are adjusted for age and gender distribution in the area using indirect standardization. 32 Observed relative rates are calculated as follows:
Observed population-based hospitalization rate
The rates are centered at 1 because over all areas the observed number of events is equal to the number expected. Because population-based hospitalization rate equals diseasebased hospitalization rate multiplied by disease prevalence, population-based hospitalization rates are similar to diseasebased hospitalization rates only when disease prevalence varies little across the area from what is expected based on age and gender alone.
We ranked areas from lowest to highest according to their population-based hospitalization rates. Areas in the first decile (ranks 1-7) had the lowest rates and those in the last decile (ranks 65-71) had the highest. We call areas in these deciles extreme. For each extreme area, we examined its ranking according to its disease-based hospitalization rate. We present detailed results for heart failure (DRG 127), which has over 10,000 people treated as inpatients and nearly 40,000 treated as outpatients only.
Using the observed rates as calculated in the previous equations as estimates of "true" underlying rates does not explicitly take into account random variation of "true" rates across areas. 8 To estimate "true" rates more accurately, we used a hierarchical Bayesian model [33] [34] [35] [36] [37] [38] -specifically, a Poisson model with area treated as a random effect. We validated the model by showing that, across the 71 areas, inpatient and outpatient counts generated from the model corresponded well to the observed counts. (Details of the model and validation are available from the first author.)
We estimated "true" rates in each area using Gibbs sampling as implemented in WINBUGS 1.4.
39 These estimates can be thought of as weighted averages of the observed rates in each area (as calculated from the previous formulas) and the average rate over all areas in the state (which is 1, because our rates are relative rates). Thus, the weighting "shrinks" each observed rate toward 1. We refer to these estimates as "shrunken" rates. The areas with the most shrinkage are those with the most extreme observed rates and those with the fewest people. Shrunken estimates are more accurate than traditional estimates in predicting small-area hospitalization rates. 29 Based on the posterior means from Gibbs sampling, we ranked each area using both population-based and diseasebased rates. Ranks, even when based on shrunken estimates, are inherently unstable. 40 To describe the extent to which areas were ranked differently when using population-based versus disease-based rates, we estimated how often (in repeated Gibbs samples from the appropriate posterior distribution) the rank produced by the disease-based rate differed from the rank produced by the population-based rate by at least 2 deciles (14 or more ranks). In summarizing results across conditions, we report the number of the 14 extreme areas in which it was "more likely than not" (ie, probability Ն 0.50) that the disease-based rank differed by more than 2 deciles from the population-based rank. Table 1 shows the number of people hospitalized and the number treated on an outpatient-only basis for each condition.
RESULTS
We use heart failure (DRG 127) to illustrate the analyses. Table 2 shows the effect of shrinkage on both the population-based and the disease-based hospitalization rates for those areas in the lowest and highest decile based on their observed rates. For example, although the area with the smallest observed population-based hospitalization rate had an observed (relative) rate of 0.43, its shrunken rate was 0.62. The area ranked 65th according to its observed populationbased rate was particularly small. Its shrunken rate was pulled a lot toward 1 (from 1.30 -1.08), such that after shrinkage it was ranked only 49th. Although shrunken estimates were less spread out than the observed rates, shrinkage rarely caused large changes in rank. In fact, among the 28 observed-versusshrunken rank comparisons in Table 2 , 22 changed by 3 ranks or less and only 2 comparisons (both relating to the very small area with 909 residents) changed ranks by 14 or more.
We were primarily interested in the extent to which areas identified as extreme (ie, in the top and bottom deciles) according to their population-based hospitalization rate were also extreme according to their disease-based hospitalization rate. Table 3 shows for heart failure the shrunken populationbased hospitalization rate and rank, and the shrunken diseasebased hospitalization rate and rank, for the most extreme 14 areas according to their shrunken population-based rates. The area with the lowest population-based hospitalization rate (62% of expected, rank 1) also had a low disease-based hospitalization rate (78% of expected, rank 3). We call the area with the second lowest population-based hospitalization rate (rank 2) "area A" (we refer to it again later). Although area A's population-based hospitalization rate was 65% of expected, based on its disease-based hospitalization rate (105% of expected), it was ranked 41st. Of the 7 areas ranked in the first decile (ranks 1-7) based on their population-based hospitalization rate, 4 were ranked in the 3rd decile or higher (rank 22 or higher) based on their disease-based hospitaliza- tion rate. Of the 7 areas in the 10th decile (ranks 65-71) based on their population-based hospitalization rate, 3 were in the 7th decile or lower (ranks 50 or lower) based on their disease-based hospitalization rate. Notably, when using the disease-based hospitalization rate, 2 areas in the highest population-based hospitalization rate decile (ranks 65 and 67) were ranked lower (ranks 33 and 11 respectively) than 2 of the areas in the lowest population-based hospitalization rate decile (population-based hospitalization rate ranks 2 and 6, which were ranked 41st and 38th based on disease-based hospitalization rate). The right 2 columns in Table 3 , which show estimates of disease prevalence, demonstrate why population-based hospitalization rates and disease-based hospitalization rates can be so different. Area A, discussed earlier, had 62% of the amount of disease expected (the lowest estimated disease prevalence). Its low population-based hospitalization rate was largely a reflection of the low disease prevalence in the area. After taking disease prevalence into account (by using the disease-based hospitalization rate), the area actually had 5% more hospitalizations than expected. All 7 areas with the lowest population-based hospitalization rates had very low levels of disease and, to a large extent, this explains their very low population-based hospitalization rates. The highest decile demonstrates the same phenomenon. The area ranked 67th in terms of its population-based hospitalization rate had 44% more disease than expected. When this was taken into account, the proportion hospitalized in the area was 90% of expected rather than the 29% more than expected indicated by the population-based hospitalization rate. Figure 1 is a box plot of shrunken population-based and disease-based hospitalization rates for the 15 conditions. Many of the conditions exhibited more variability in rates than heart failure. For most of the conditions, populationbased rates varied from around 50% of expected to 50% more than expected. Disease-based rates also varied considerably, although in most conditions somewhat less than populationbased rates. Table 4 shows for each of the 15 conditions for areas in the top decile of population-based hospitalization rates, what their rank would be according to their disease-based hospitalization rate. To illustrate, for transient ischemic attacks (TIAs, top row) the area ranked highest (71st) based on its population-based hospitalization rate was ranked 62nd based on its disease-based hospitalization rate; the area ranked second highest based on its population-based hospitalization rate (70th) was ranked 49th based on its disease-based hospitalization rate. The numbers in parentheses indicate the fraction of the time in repeated Gibbs samples from the posterior distributions of the ranks that the 2 ranks differed by at least 2 deciles (shown if the fraction was Ն 0.50). For example, for TIA for the highest ranked area based on its population-based hospitalization rate, there was a 0.50 chance that the disease-based hospitalization rate rank differed from the population-based hospitalization rate rank by at least 2 deciles. For the second highest ranked area based on its population-based hospitalization rate, the probability was 0.80. For 4 conditions (heart failure, peripheral vascular disorders, arrhythmia, and back problems), 10 or 11 of the 14 extreme areas according to their population-based hospitalization rate were "more likely than not" (ie, with a probability of 0.50 or greater) to differ by at least 2 deciles when ranked according to their disease-based hospitalization rate. For 7 conditions (TIA, chronic obstructive pulmonary disease, pneumonia, chest pain, cellulitis, diabetes, and electrolyte disorder), 5 or 6 of the 14 extreme areas based on the population-based hospitalization rate were "more likely than not" to differ by at least 2 deciles when ranked by their disease-based hospitalization rate. Only for ischemic heart disease, angina, and syncope was it more likely than not that most of the areas (12 or more) were within 2 deciles when ranked by each rate.
DISCUSSION
Population-based hospitalization rates varied widely across small areas in Massachusetts. However, disease prevalence also varied widely. Because of differences in disease prevalence, areas with extreme population-based hospitalization rates were not necessarily areas in which a particularly high or low proportion of those with the disease were admitted to the hospital, relative to what was expected given the age and gender distribution in the area.
Our approach relies on claims data to identify people with specific diseases. Because of concern about the validity of disease identification from outpatient codes, we conducted analyses using both a stringent definition (the series method) and a lenient definition (which considered all visits) for identifying disease from diagnostic codes on outpatient claims. Both analyses showed substantial differences in area ranks when calculated with population-based versus diseasebased rates. However, claims data can be imperfect in many ways and are unlikely to capture all conditions noted on the medical record. 41 Our conclusions do not depend on accurately estimating actual disease prevalence, but on estimating relative disease prevalence (ie, how much more or less disease one area has compared with another). The key assumption behind our analysis is that outpatient coding is not systematically biased across areas. However, areas with better access to technology or more specialists may identify more disease than other areas with a similar disease burden, or they may code presentations to justify use of the technology or referral to specialists. We are currently exploring the potential for such bias by examining the relationship, within areas, between specialist physician supply and claims-based disease prevalence.
Another concern when identifying disease from claims is that higher rates of coded disease may reflect better access to primary care or may be a proxy for either physician or hospital bed supply. In a Medicare population eligible for both hospital and outpatient care, however, financial access differences are at least somewhat muted. Also, by focusing on the number of people with any visit for a condition rather than total numbers of medical encounters by those with the condition, we reduce the effect of practice style on our measure of disease prevalence. If supply were the main factor driving demand, the same areas that have high rates of disease would have high rates of hospitalization among those with the disease. Correlations between disease prevalence and the proportion of those with the disease who were hospitalized were, in fact, statistically significant for 9 of the 15 conditions. However, in all 9, the correlation was negative. Finally, despite concerns about outpatient coding, CMS judges them sufficiently valid that, starting in 2004, it will accept diagnoses from either inpatient or outpatient claims to calculate health-based payments to MedicareϩChoice HMOs for the Medicare beneficiaries they enroll.
As health care costs continue to outpace general inflation, pressure is mounting to revitalize certificate-of-need programs. For example, the Wall Street Journal recently wrote: "the Big Three ͓auto companies͔ have lobbied aggressively to keep certificate-of-need programs in states such as Missouri and have fought ardently for the establishment of programs in Ohio and Indiana." 42 Vermont recently issued a request for proposal for consultation services to develop a health resource allocation plan to guide health facility planning and capital expenditures. Hospital capacity is a major focus of such programs. Motivating decisions about hospital capacity are area-specific hospitalization rates. Our analyses suggest that disease prevalence rather than population counts provide a more appropriate denominator for such rates. Unfortunately, outpatient claims are not widely available. At a minimum, our study indicates that databases with outpatient as well as inpatient claims are needed to address better the research and policy questions raised by geographic variations.
Many current quality improvement efforts examine process measures for patients with specific conditions (eg, whether specifically identified patients with heart disease receive appropriate medications or diabetic patients receive appropriate assessment and preventive therapy). Whether patients with specific conditions are hospitalized is an important process measure, both because of iatrogenic events and costs. Although we have focused on variations across geographic areas, our approach applies as well to examining variations in hospitalizations across physician practices. Because of small samples, shrinkage estimators are even more important in this setting.
Our study examined only 15 medical conditions using 1 year of data from 1 state. Also, some Medicare beneficiaries use both Veteran Administration (VA) and non-VA facilities and we have not included diagnostic or utilization data from VA facilities. 43, 44 Nonetheless, the large differences in disease prevalence across small areas that remain after adjusting for age and gender raise concerns about the value of population-based hospitalization rates for studying hospital utilization and drawing inferences about physician practice styles.
